Vanguard Group Inc. Buys 481,231 Shares of Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Vanguard increased its stake in Sabra Healthcare REIT by 1.4%, buying 481,231 shares and bringing its holding to 35,430,016 shares (about 14.21% of the company) valued at roughly $671 million.
• Sabra beat Q1 revenue and FFO estimates, raised FY‑2026 EPS guidance to $1.55–$1.59, and declared a quarterly dividend of $0.30 (annualized yield ~5.8–5.9%).
• Management said it will revisit guidance after ~ $400M of year‑to‑date investments and warned of tight skilled‑nursing deal flow and strong competition, creating near‑term uncertainty about capital deployment and payout sustainability (payout ratio ~190%).

Vanguard Group Inc. grew its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 1.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 35,430,016 shares of the real estate investment trust's stock after acquiring an additional 481,231 shares during the period. Vanguard Group Inc. owned about 14.21% of Sabra Healthcare REIT worth $671,045,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT during the third quarter valued at approximately $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT during the third quarter valued at approximately $30,000. Larson Financial Group LLC raised its stake in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock valued at $35,000 after acquiring an additional 553 shares in the last quarter. First Horizon Corp bought a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at approximately $44,000. Finally, Covestor Ltd increased its holdings in Sabra Healthcare REIT by 23,720.0% during the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust's stock valued at $45,000 after buying an additional 2,372 shares during the period. Institutional investors own 99.40% of the company's stock.

Key Stories Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Q1 top‑line and FFO beat — Sabra reported revenue of $221.8M (above estimates) and FFO of $0.39, beating consensus ($0.38), showing continued SHOP/senior‑housing contribution and improved cash flow dynamics. Sabra Healthcare (SBRA) Tops Q1 FFO and Revenue Estimates
• Positive Sentiment: FY‑2026 guidance nudged higher — company set EPS guidance of $1.55‑$1.59 vs. consensus ~1.50, implying modest upside to street earnings expectations. Press Release / Slide Deck
• Positive Sentiment: Dividend declared — quarterly dividend of $0.30/share (annualized yield ~5.8%), supporting income investor interest. (Company release)
• Positive Sentiment: Analyst support — at least one published note sets a $22 price target, indicating some analyst optimism on valuation upside. Analysts Set Sabra Healthcare REIT, Inc. NASDAQ: SBRA Price Target at $22.00
• Neutral Sentiment: SHOP/senior‑housing contribution highlighted — management and coverage note this was a driver of the quarter, an operational detail investors should watch for sustainability. Sabra Showcases Strong SHOP‑Driven Quarter
• Neutral Sentiment: Earnings metrics mixed — GAAP EPS of $0.16 met estimates but remains below last year’s quarter (affected by mix and non‑recurring items); slides and full call transcript are available for detail. Earnings Call Transcript / Presentation Q1 Presentation
• Negative Sentiment: Guidance subject to review — management said it will “revisit” 2026 guidance in Q2 after year‑to‑date investments of ~$400M, creating near‑term uncertainty about capital allocation and payout sustainability. Sabra Outlines Revisiting 2026 Guidance
• Negative Sentiment: Tighter deal flow and competition — CEO warned skilled‑nursing acquisition activity is tight and competition from private OpCo/PropCo buyers is fierce, which may limit attractive deployment opportunities and pressure future growth. CEO: Skilled Nursing Deal Flow Tight

Sabra Healthcare REIT Stock Performance

Shares of SBRA stock opened at $20.36 on Monday. The firm has a market cap of $5.13 billion, a price-to-earnings ratio of 32.32, a PEG ratio of 1.63 and a beta of 0.67. The company's 50 day moving average is $20.23 and its 200 day moving average is $19.36. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a 52-week low of $17.04 and a 52-week high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business had revenue of $221.75 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the previous year, the company earned $0.37 earnings per share. The business's revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Shareholders of record on Friday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.9%. The ex-dividend date of this dividend is Friday, May 15th. Sabra Healthcare REIT's payout ratio is currently 190.48%.

Analyst Ratings Changes

SBRA has been the topic of several research reports. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a "hold" rating in a report on Friday, March 13th. Citigroup lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a "buy" rating in a report on Wednesday, February 18th. Weiss Ratings lowered shares of Sabra Healthcare REIT from a "buy (a-)" rating to a "buy (b+)" rating in a report on Friday. UBS Group lifted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a report on Thursday, February 19th. Finally, Wells Fargo & Company lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an "overweight" rating in a report on Thursday, March 26th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $22.00.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.